Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Reset all filters
01 3Strides Pharma Science
02 52care4
03 3ARCUTIS CANADA, INC.
04 1Abacus Medicine
05 1Accord healthcare
06 2Alkem Laboratories
07 3Arcutis Biotherapeutics
08 11AstraZeneca
09 2Aurobindo Pharma Limited
10 2Hetero Drugs
11 1KMS Health Center
12 1MS Pharma
13 2MSN Laboratories
14 1Medartuum
15 2Micro Labs Limited
16 3ORIFARM GROUP AS
17 1Orchid Pharma
18 1PHARMOBEDIENT
19 1Precise Group
20 1Prinston
21 2Senores Pharmaceuticals
22 1Takeda Pharmaceutical
23 4Torrent Pharmaceuticals Limited
24 2Zydus Pharmaceuticals
25 2Blank
Reset all filters
01 4Antic-calc Tablet, Film Coated
02 2CREAM
03 2CREAM;TOPICAL
04 1FCT
05 1FOAM
06 1FOAM;TOPICAL
07 13Film Coated Tablet
08 1Roflumilast 500Mcg 30 Joined' Oral Use
09 3TABLET
10 22TABLET;ORAL
11 6Tablet
12 2Tablet, film-coated
Reset all filters
01 1Allowed
02 7Approved
03 3DISCN
04 4Deregistered
05 2Generic
06 1Generic CTD, BE- Available
07 1Generic EU CTD
08 1Originator
09 22RX
10 16Blank
Reset all filters
01 130 Daxas 500Mcg Film-Coated Tablets
02 130 Libertek 500Mcg Film-Coated Tablets
03 1Charcoal
04 2DALIRESP
05 1DAXAS
06 1Daliresp
07 7Daxas
08 1Daxas 500 µg
09 1Daxas ug
10 1Libertek
11 2Quadruple
12 20ROFLUMILAST
13 1Roflumilast
14 2Roflumilast 2Care4
15 2Roflumilast Accord
16 1Roflumilast Medartuum
17 1Roflumilast Orifarm
18 6ZORYVE
19 6Blank
Reset all filters
01 4Canada
02 6India
03 1Italy
04 1Jordan
05 6Norway
06 1South Africa
07 2Spain
08 11Sweden
09 1Switzerland
10 25USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 500MCG
Packaging :
Approval Date : 2020-03-30
Application Number : 208247
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 250MCG
Packaging :
Approval Date : 2023-06-20
Application Number : 208247
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name : Roflumilast
Dosage Form : Tablet
Dosage Strength : 500MCG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 250MCG
Packaging :
Approval Date : 2023-04-18
Application Number : 212490
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DALIRESP
Dosage Form : TABLET;ORAL
Dosage Strength : 500MCG
Packaging :
Approval Date : 2011-02-28
Application Number : 22522
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DALIRESP
Dosage Form : TABLET;ORAL
Dosage Strength : 250MCG
Packaging :
Approval Date : 2018-01-23
Application Number : 22522
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 500MCG
Packaging :
Approval Date : 2018-11-23
Application Number : 208213
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 250MCG
Packaging :
Approval Date : 2023-04-18
Application Number : 208213
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 500MCG
Packaging :
Approval Date : 2019-03-22
Application Number : 208180
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 250MCG
Packaging :
Approval Date : 2023-04-18
Application Number : 208180
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 250MCG
Packaging :
Approval Date : 2022-09-07
Application Number : 208256
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 500MCG
Packaging :
Approval Date : 2022-09-07
Application Number : 208256
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 500MCG
Packaging :
Approval Date : 2022-05-10
Application Number : 208299
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 500MCG
Packaging :
Approval Date : 2018-10-03
Application Number : 208236
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 250MCG
Packaging :
Approval Date : 2023-10-19
Application Number : 208236
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 500MCG
Packaging :
Approval Date : 2018-08-06
Application Number : 208272
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 250MCG
Packaging :
Approval Date : 2024-10-18
Application Number : 208272
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 500MCG
Packaging :
Approval Date : 2022-02-10
Application Number : 208303
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 250MCG
Packaging :
Approval Date : 2023-04-18
Application Number : 208303
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROFLUMILAST
Dosage Form : TABLET;ORAL
Dosage Strength : 500MCG
Packaging :
Approval Date : 2018-07-13
Application Number : 208257
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF